(Q37849513)

24 August 2017

1 reference

title

Imaging in prostate cancer diagnosis: present role and future perspectives (English)

1 reference

24 August 2017

0 references

1 reference

1 reference

4

1 reference

24 August 2017

6

Marco Racioppi

1 reference

24 August 2017

1

Francesco Pinto

1 reference

24 August 2017

Angelo Totaro

2

1 reference

24 August 2017

Alessandro Calarco

3

1 reference

24 August 2017

Andrea Volpe

5

1 reference

24 August 2017

Alessandro D'Addessi

7

1 reference

24 August 2017

Gaetano Gulino

8

1 reference

24 August 2017

PierFrancesco Bassi

9

1 reference

24 August 2017

language of work or name

1 reference

2 March 2011

1 reference

24 August 2017

published in

Urologia Internationalis

1 reference

24 August 2017

volume

86

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

373-382

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

24 August 2017

cites work

1 reference

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

Value of magnetic resonance imaging in prostate cancer diagnosis

21 January 2018

1 reference

Optimization of prostate biopsy strategy using computer based analysis.

21 January 2018

1 reference

Challenges in clinical prostate cancer: role of imaging

21 January 2018

1 reference

Functional magnetic resonance imaging in prostate cancer

21 January 2018

1 reference

Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging

21 January 2018

1 reference

The value of endorectal MRI in the early diagnosis of prostate cancer

21 January 2018

1 reference

Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy

21 January 2018

1 reference

Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer

21 January 2018

1 reference

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

21 January 2018

1 reference

Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer

21 January 2018

1 reference

Extended and saturation needle biopsy for the diagnosis of prostate cancer

21 January 2018

1 reference

[Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].

21 January 2018

1 reference

Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.

21 January 2018

1 reference

Contrast-enhanced sonography for prostate cancer detection in patients with indeterminate clinical findings

21 January 2018

1 reference

Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI.

21 January 2018

1 reference

Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent

21 January 2018

1 reference

Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report

21 January 2018

1 reference

Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection.

21 January 2018

1 reference

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy

21 January 2018

1 reference

Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies

21 January 2018

1 reference

Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography

21 January 2018

1 reference

MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results

21 January 2018

1 reference

Functional MR imaging of prostate cancer

21 January 2018

1 reference

Multiparametric magnetic resonance imaging in prostate cancer: present and future

21 January 2018

1 reference

Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy

21 January 2018

1 reference

Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

21 January 2018

1 reference

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines

21 January 2018

1 reference

Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer

21 January 2018

1 reference

Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience

21 January 2018

1 reference

Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

21 January 2018

1 reference

Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

21 January 2018

1 reference

Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography

21 January 2018

1 reference

Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results.

21 January 2018

1 reference

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging

21 January 2018

1 reference

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

21 January 2018

1 reference

Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results

21 January 2018

1 reference

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

21 January 2018

1 reference

High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat.

21 January 2018

1 reference

Diffusion-weighted MRI in the body: applications and challenges in oncology

21 January 2018

1 reference

Diffusion-weighted imaging of prostate cancer.

21 January 2018

1 reference

Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions

21 January 2018

1 reference

Dynamic contrast enhanced MRI in prostate cancer

21 January 2018

1 reference

How good is MRI at detecting and characterising cancer within the prostate?

21 January 2018

1 reference

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

21 January 2018

1 reference

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.

21 January 2018

1 reference

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000324515

1 reference

24 August 2017

1 reference